Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits
- 1 July 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (6) , 1479-1485
- https://doi.org/10.1038/sj.bjp.0702668
Abstract
The effects of atorvastatin (3 mg kg(-1)) and simvastatin (3 mg kg(-1)) on hepatic enzyme activities involved in very low density lipoprotein metabolism were studied in coconut oil/cholesterol fed rabbits. Plasma cholesterol and triglyceride levels increased 19 and 4 fold, respectively, after 7 weeks of feeding. Treatment with statins during the last 4 weeks of feeding abolished the progression of hypercholesterolaemia and reduced plasma triglyceride levels. 3-Hydroxy-3-methyl-glutaryl Coenzyme A reductase, acylcoenzyme A:cholesterol acyltransferase, phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities were not affected by drug treatment. Accordingly, hepatic free cholesterol, cholesteryl ester and triglyceride content were not modified. Simvastatin treatment caused an increase (72%) in lipoprotein lipase activity without affecting hepatic lipase activity. Atorvastatin caused a reduction in hepatic phospholipid content and a compensatory increase in CTP:phosphocholine cytidylyl transferase activity. The results presented in this study suggest that, besides the inhibitory effect on 3-hydroxy-3-methyl-glutaryl Coenzyme A reductase, simvastatin and atorvastatin may have additional effects that contribute to their triglyceride-lowering ability.Keywords
This publication has 44 references indexed in Scilit:
- AtorvastatinDrugs, 1997
- Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanismsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assemblyBiochemistry and Cell Biology, 1990
- Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Effects of MK-733 (simvastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on intestinal acylcoenzyme A: cholesterol acyltransferase activity in rabbitsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959